1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea

C24H30F3N5OS — CID 174220587

IUPAC1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea
SMILESCCC(CCC(F)(F)F)NC(=O)N(CC)[C@H](C)c1cccc(-c2cn3ccnc3c(SC)n2)c1
InChIInChI=1S/C24H30F3N5OS/c1-5-19(10-11-24(25,26)27)29-23(33)32(6-2)16(3)17-8-7-9-18(14-17)20-15-31-13-12-28-21(31)22(30-20)34-4/h7-9,12-16,19H,5-6,10-11H2,1-4H3,(H,29,33)/t16-,19?/m1/s1
InChIKeyMNQFBTPYZRVMRO-VTBWFHPJSA-N
MW493.60 g/mol
LogP6.33
Rot. Bonds9

About 1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea

1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea (PubChem CID 174220587) has the molecular formula C24H30F3N5OS and a molecular weight of 493.60 g/mol. Its IUPAC name is 1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea.

Molecular Properties

Compound Name1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea
PubChem CID174220587
Molecular FormulaC24H30F3N5OS
Molecular Weight493.60 g/mol
Exact Mass493.21
IUPAC Name1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea
SMILESCCC(CCC(F)(F)F)NC(=O)N(CC)[C@H](C)c1cccc(-c2cn3ccnc3c(SC)n2)c1
InChIInChI=1S/C24H30F3N5OS/c1-5-19(10-11-24(25,26)27)29-23(33)32(6-2)16(3)17-8-7-9-18(14-17)20-15-31-13-12-28-21(31)22(30-20)34-4/h7-9,12-16,19H,5-6,10-11H2,1-4H3,(H,29,33)/t16-,19?/m1/s1
InChIKeyMNQFBTPYZRVMRO-VTBWFHPJSA-N
XLogP6.33
TPSA62.53 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500493.60
LogP ≤ 56.33
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea?
The IUPAC name of 1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea (CID 174220587) is 1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea.
What is the SMILES notation for 1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea?
The canonical SMILES for 1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea is CCC(CCC(F)(F)F)NC(=O)N(CC)[C@H](C)c1cccc(-c2cn3ccnc3c(SC)n2)c1.
What is the InChIKey of 1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea?
The InChIKey is MNQFBTPYZRVMRO-VTBWFHPJSA-N. The full InChI is InChI=1S/C24H30F3N5OS/c1-5-19(10-11-24(25,26)27)29-23(33)32(6-2)16(3)17-8-7-9-18(14-17)20-15-31-13-12-28-21(31)22(30-20)34-4/h7-9,12-16,19H,5-6,10-11H2,1-4H3,(H,29,33)/t16-,19?/m1/s1.
What are the key properties of 1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea?
1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea has a molecular weight of 493.60 g/mol, XLogP of 6.33, 9 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 1-ethyl-1-[(1R)-1-[3-(8-methylsulfanylimidazo[1,2-a]pyrazin-6-yl)phenyl]ethyl]-3-(6,6,6-trifluorohexan-3-yl)urea is sourced from PubChem (CID 174220587), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).